Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.500
-0.100 (-2.78%)
Apr 29, 2026, 2:11 PM EDT - Market open
LIXT Market Cap
LIXT has a market cap or net worth of $40.66 million as of April 29, 2026. Its market cap has increased by 1,170.71% in one year.
Market Cap
40.66M
Enterprise Value
36.13M
1-Year Change
1,170.71%
Ranking
Category
Stock Price
$3.50
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $40.66M, a decrease of -14.21%. That is a compound annual growth rate of -2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 41.80M | 86.61% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 47.29M |
| Atossa Therapeutics | 46.93M |
| Rallybio | 46.44M |
| Dogwood Therapeutics | 44.76M |
| Mereo BioPharma Group | 44.72M |
| Lite Strategy | 42.54M |
| Sensei Biotherapeutics | 42.27M |
| Rein Therapeutics | 41.78M |